Beta-glucan (oat / barley)
Oat soluble fibre with an EU-authorised claim for lowering blood cholesterol at 3 g/day.
- Evidence
- Strong evidenceGRADE certainty: High
- Typical dose
- 3 g/day of beta-glucan from oats or barley, typically met with ~75 g of oatmeal, ~40 g of oat bran, or a beta-glucan concentrate
- Time to effect
- LDL cholesterol changes typically over 4–6 weeks of consistent daily intake
- Safety
- Has documented cautions
Evidence ratings summarise published research on Beta-glucan (oat / barley) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Beta-glucan (oat / barley)
Interactions
Taking any medication?
Check Beta-glucan (oat / barley) against it.
Why
Beta-glucan from oats holds an EU-authorised health claim for lowering blood cholesterol at 3 g/day. A meta-analysis of 28 RCTs found at least 3 g/day of oat beta-glucan lowered LDL cholesterol by about 0.25 mmol/L and total cholesterol by 0.30 mmol/L, with no significant effect on HDL or triglycerides. Support for barley beta-glucan comes from a NICE surveillance summary of meta-analyses.
How it works
Forms a viscous gel in the small intestine that binds bile acids, increasing their faecal loss and forcing hepatic cholesterol-to-bile conversion, lowering circulating LDL.
Expected onset · LDL cholesterol changes typically over 4–6 weeks of consistent daily intake
How to take
Dosage
3 g/day of beta-glucan from oats or barley (the EFSA-cited threshold), typically met with ~75 g of oatmeal, ~40 g of oat bran, or a beta-glucan concentrate.
Timing
With breakfast or any carbohydrate-containing meal
On the label
Look for products stating 'beta-glucan from oats' or 'beta-glucan from barley' with dose per serving, the EFSA claim requires the product to deliver at least 1 g per serving.
Studied in
Adults with elevated LDL cholesterol, aiming for a food-first approach.
Safety
Evidence
EU authorised claim: oat beta-glucan has been shown to lower blood cholesterol at 3 g/day. Whitehead 2014 Am J Clin Nutr meta-analysis (28 RCTs): at least 3 g/day of oat beta-glucan lowered LDL cholesterol by 0.25 mmol/L and total cholesterol by 0.30 mmol/L, with no significant effect on HDL or triglycerides.
GRADE certainty: High — EU authorised claim
- EFSA authorised claim Reg 432/2012, 'Oat beta-glucan has been shown to lower/reduce blood cholesterol' (3 g/day)
- Whitehead et al., Am J Clin Nutr 2014, oat beta-glucan and LDL meta-analysis
- NICE guideline (2019): Cardiovascular disease: risk assessment and reduction, including lipid modification – CG181 (4-year surveillance evidence review, Appendix A)
Questions people ask
Does Beta-glucan (oat / barley) work?
EU authorised claim: oat beta-glucan has been shown to lower blood cholesterol at 3 g/day. Whitehead 2014 Am J Clin Nutr meta-analysis (28 RCTs): at least 3 g/day of oat beta-glucan lowered LDL cholesterol by 0.25 mmol/L and total cholesterol by 0.30 mmol/L, with no significant effect on HDL or triglycerides. Certainty of the evidence: High, EU authorised claim.
How is Beta-glucan (oat / barley) taken?
3 g/day of beta-glucan from oats or barley (the EFSA-cited threshold), typically met with ~75 g of oatmeal, ~40 g of oat bran, or a beta-glucan concentrate. Timing: With breakfast or any carbohydrate-containing meal. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Bloating and flatulence in the first 1–2 weeks as the colonic microbiota adapts. Can slow absorption of some medications. Separate dosing by 1–2 hours. Avoid in active inflammatory bowel disease flare (high-fibre may aggravate). Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: EFSA authorised claim Reg 432/2012, 'Oat beta-glucan has been shown to lower/reduce blood cholesterol' (3 g/day); Whitehead et al., Am J Clin Nutr 2014, oat beta-glucan and LDL meta-analysis; NICE guideline (2019): Cardiovascular disease: risk assessment and reduction, including lipid modification – CG181 (4-year surveillance evidence review, Appendix A).
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.